Literature DB >> 8994115

Enhanced expression of chemotactic receptors in multiple sclerosis lesions.

U Müller-Ladner1, J L Jones, R A Wetsel, S Gay, C S Raine, S R Barnum.   

Abstract

We have previously shown that astrocytes and microglia express the receptors for C5a, interleukin-8 (IL-8) and N-formyl-Met-Leu-Phe (FMLP) in vitro. The expression and function of chemotactic receptors in the central nervous system (CNS) is, however, largely unexplored. In this study, we examined tissue sections from normal human brain and active, chronic active and chronic silent multiple sclerosis (MS) lesions for the expression of the receptors for C5a, IL-8 and FMLP by immunohistochemistry. In normal brain tissue, the expression of all three receptors was seen at low levels on astrocytes and microglia. In contrast, expression for all three receptors was markedly elevated on foamy macrophages in the acute and chronic active MS lesions. In addition, fibrous astrocytes stained intensely for the C5a receptor in the chronic active disease. Receptor expression in the chronic silent lesion was low and similar to that seen in normal brain, with staining confined to a few hypertrophic astrocytes and foamy macrophages. These are the first studies to demonstrate expression of these receptors in the CNS and elevated receptor expression in inflammatory MS lesions. The data suggest that these chemotactic receptors may play a role in inflammatory responses in MS and possibly in other CNS diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994115     DOI: 10.1016/s0022-510x(96)00217-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

3.  Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.

Authors:  D Kempuraj; M Tagen; B P Iliopoulou; A Clemons; M Vasiadi; W Boucher; M House; A Wolfberg; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.

Authors:  Sarah A Ingersoll; Carol B Martin; Scott R Barnum; Brian K Martin
Journal:  Mol Immunol       Date:  2010-09-01       Impact factor: 4.407

Review 5.  Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.

Authors:  Pablo Iribarren; Ye Zhou; Jinyue Hu; Yingying Le; Ji Ming Wang
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Kai Bihler; Eugenia Kress; Stefan Esser; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Mol Neurosci       Date:  2017-05-02       Impact factor: 3.444

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

8.  Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.

Authors:  B P Morgan; M Griffiths; H Khanom; S M Taylor; J W Neal
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

9.  Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology.

Authors:  Maria I Fonseca; Susan O McGuire; Scott E Counts; Andrea J Tenner
Journal:  J Neuroinflammation       Date:  2013-02-08       Impact factor: 8.322

10.  The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis.

Authors:  Nicole Trager; Jonathan T Butler; Azizul Haque; Swapan K Ray; Craig Beeson; Naren L Banik
Journal:  J Clin Cell Immunol       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.